Skip to main content

Peer Review reports

From: CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure

Original Submission
23 Dec 2020 Submitted Original manuscript
13 Jul 2021 Reviewed Reviewer Report
25 Jul 2021 Reviewed Reviewer Report
5 Aug 2021 Author responded Author comments - Elodie COQUAN
Resubmission - Version 2
5 Aug 2021 Submitted Manuscript version 2
2 Sep 2021 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
6 Sep 2021 Editorially accepted
25 Sep 2021 Article published 10.1186/s12885-021-08758-9

You can find further information about peer review here.

Back to article page